KUMUDHA BALAKRISHNAN to Rituximab
This is a "connection" page, showing publications KUMUDHA BALAKRISHNAN has written about Rituximab.
Connection Strength
0.026
-
A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL. Oncotarget. 2017 Mar 28; 8(13):22104-22112.
Score: 0.026
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.